Cerebras Stock And 2 Growth Picks for AI Infrastructure Investors
Unusual Machines UMAC | 0.00 |
Global bond yields are pressing higher as markets react to stubborn inflation pressures from rising energy costs. That backdrop is punishing heavily indebted companies and rewarding businesses with cleaner balance sheets and clear earnings growth potential. The Healthy high growth potential screener filters for exactly that mix. This article highlights three stocks from the screener so you can see how this theme translates into real opportunities today.
The three stocks below are just a small sample, and the full Healthy high growth potential screen surfaces 1,531 more companies with similarly compelling stories that are not covered here. If you want to move faster, head straight to the Healthy high growth potential screener to identify and analyze the highest conviction ideas that fit your criteria.
Unusual Machines (UMAC)
Unusual Machines is a US based commercial drone company that designs small drones and key components for enterprise, government and retail buyers, which directly ties it to the Healthy high growth potential theme through product driven earnings potential. The business currently generates about US$31.9 million of revenue from its Aerospace & Defense segment, entirely in the United States, and has a market cap of about US$1.5b.
Investors interested in earnings growth stories may note that Unusual Machines is building a domestically focused drone and components business at a time when tariffs and policy support are influencing some US buyers toward local suppliers. The Lantronix partnership to add edge AI into flight control systems is intended to position its drones for higher value enterprise and government use cases. The company is still loss making, relies on external funding and has experienced shareholder dilution, so execution on capacity expansion and government contracts is an important factor for investors to monitor.
Unusual Machines is trying to turn tariffs, local sourcing and edge AI into a real commercial drone earnings story. Yet the real twist may sit in the 2 key rewards and 3 important warning signs (2 are major!)
Build your own high growth shortlist around Unusual Machines
Unusual Machines and the other two stocks in this article all came from the same screener, but the real advantage is in creating filters that match how you think about growth, balance sheets and risk. Use our flexible Screener to craft your own stock set, or lean on the foundations of our curated Investing Ideas.
Dutch Bros (BROS)
Dutch Bros runs a fast growing chain of drive thru coffee shops across the United States, with the Healthy high growth potential theme most clearly reflected in its company operated stores that generated about US$1.7b of revenue in the latest period, alongside roughly US$141 million from franchising and other activities. All of this revenue currently comes from the US market. The stock has a market cap of about US$9.5b.
Dutch Bros provides focused exposure to drive thru coffee, with earnings dependent on the opening of new shops and the impact of digital loyalty programs, energy drinks and an expanding menu on sales per store. Forecasts currently indicate strong revenue and earnings growth, improving margins and potential upside if expectations are met. At the same time, heavy unit expansion, rising labor costs, insider selling and a high P/E mean the story leaves little room for disappointment. These factors together make this coffee stock worth a closer look.
Dutch Bros’ rapid store roll out and loyalty driven sales story is gaining momentum, yet the real tension sits in how forecasts line up with insider selling and that elevated P/E multiple. The analyst forecasts for Dutch Bros could reveal what the market might be missing.
Cerebras Systems (CBRS)
Cerebras Systems builds wafer scale AI compute platforms that are designed to speed up Generative AI training and inference for hyperscalers, model labs and enterprises, which is the clearest link to the Healthy high growth potential theme. The company generates about US$680.7 million of revenue from its Semiconductors segment and serves customers across the United States, Europe, the Middle East, Africa and other regions. Cerebras Systems has a market cap of about US$52.2b.
Cerebras Systems is drawing attention because its wafer scale CS systems are directly aimed at the surge in AI infrastructure spending and are already tied to high profile partners such as OpenAI, AWS and AMD. Analysts expect strong earnings and revenue growth over the next few years, yet the stock is still priced below some estimated fair value models, which adds interest for growth focused investors. The flip side is clear: Cerebras is not yet consistently profitable, relies on higher risk external funding and customer concentration around a few large AI players leaves the growth story exposed if any of those relationships change.
Cerebras Systems is riding the AI infrastructure wave, yet its valuation debate still feels unfinished. The DCF valuation analysis for Cerebras Systems could show whether today’s enthusiasm masks a critical twist in the story.
Seeking Fresh Alternatives Before They Fly
Market momentum keeps shifting and the most interesting ideas often move first. Scan fresh stock sets before they get widely noticed, while it matters, and consider opportunities early.
- Spot fast movers in niche corners of the market by scanning the 20 high quality undiscovered gems that still sit under the radar for now.
- Explore income-focused opportunities while prices are still settling by reviewing the curated 11 dividend fortresses that may remain relevant when momentum names lose steam.
- Monitor the next stage of the AI build out by checking the focused 56 AI infrastructure stocks before capital flows concentrate on a limited set of stocks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
